从“疏肝养心调神之法”探讨冠心病合并焦虑症的辨治
To Explore the Differentiation and Treatment of Coronary Heart Disease Combined with Anxiety from “Soothing Liver and Nourishing Heart and Regulating Spirit”
DOI: 10.12677/acm.2024.14123248, PDF,   
作者: 段伟刚*:黑龙江中医药大学研究生院,黑龙江 哈尔滨;王 岩#:黑龙江中医药大学附属第一医院中医经典病房,黑龙江 哈尔滨
关键词: 冠心病合并焦虑症疏肝养心调神柴胡加龙骨牡蛎汤Coronary Heart Disease Combined with Anxiety Soothing Liver and Nourishing Heart and Regulating Spirit Bupleurum and Keel Oyster Decoction
摘要: 冠心病合并焦虑抑郁是心血管病内科临床常见疾病,具有发病率、死亡率均高的特点,西医治疗此病不良反应多见导致患者不能坚持服药,此时中医药防治本病的优势逐渐显现。在中医学看来冠心病合并焦虑症应属“胸痹”“郁证”等范畴,其最关键因素为肝郁气滞、气虚血瘀、心神失养。临床中常以“疏肝养心调神之法”为治疗思想,疗效甚佳,以此发挥中医特色优势,提高患者远期预后。
Abstract: Coronary heart disease combined with anxiety and depression is a common clinical disease in cardiovascular medicine, with high morbidity and mortality characteristics. The adverse reactions of Western medicine in the treatment of this disease often lead to patients unable to adhere to medication. At this time, the advantages of traditional Chinese medicine in the prevention and treatment of this disease gradually emerged. In the view of traditional Chinese medicine, coronary heart disease combined with anxiety should belong to the categories of “chest impediment” and “depression syndrome”, and the most key factors are liver-qi stagnation, qi deficiency and blood stasis, and mental discontentment. In clinical practice, “soothing liver and nourishing heart and regulating spirit” is often used as the therapeutic idea, and the curative effect is very good, so as to give full play to the advantages of TCM characteristics and improve the long-term prognosis of patients.
文章引用:段伟刚, 王岩. 从“疏肝养心调神之法”探讨冠心病合并焦虑症的辨治[J]. 临床医学进展, 2024, 14(12): 1518-1523. https://doi.org/10.12677/acm.2024.14123248

参考文献

[1] 国家卫生计生委合理用药专家委员会, 中国药师协会. 冠心病合理用药指南(第2版) [J]. 中国医学前沿杂志(电子版), 2018, 10(6): 1-130.
[2] 何梦娟, 赵明君. 赵明君治疗冠心病合并焦虑症经验[J]. 中西医结合心脑血管病杂志, 2020, 18(4): 691-692.
[3] 宁博, 葛腾, 吴永青, 等. 基于“畅络调神”思想探析冠心病合并焦虑症因机证治[J]. 现代中西医结合杂志, 2023, 32(22): 3167-3172.
[4] Chen, Y., Xiao, X., Xu, X., et al. (2021) Traditional Chinese Medicine in the Prevention and Treatment of Stable Angina Pectoris in Patients with Coronary Heart Disease Based on the Theory of “Phlegm and Blood Stasis” under Guidance of Evidence Based Medicine: A Prospective Cohort Study. Journal of Traditional Chinese Medicine, 41, 150-156.
[5] 邵凯栋, 符佳美, 周亚滨. 周亚滨教授从“木郁-疏肝”论治心脏神经官能症的经验[J]. 中国中医急症, 2024, 33(10): 1835-1837.
[6] 刘丰伟, 刘思雨, 王茂凯, 等. 周亚滨教授以“安、补、通”治疗思想应用于冠心病合并焦虑抑郁经验[J]. 中国中医急症, 2024, 33(8): 1477-1480.
[7] 蔡双洁, 方居正. 川芎及其药对研究进展[J]. 中华中医药学刊, 2024, 42(8): 244-248.
[8] 戴慧, 覃欣怡, 端木彦涛, 等. 茯神的化学成分、药理作用及质量控制研究进展[J]. 江西中医药, 2022, 53(10): 68-72.
[9] 张懿, 张良洁, 卞雷斯, 等. 柴胡加龙骨牡蛎汤治疗心悸病的研究进展[J]. 中国医药, 2022, 17(1): 136-139.
[10] 姜希红, 刘树民. 黄芩药理作用及其化学物质基础研究[J]. 中国药师, 2020, 23(10): 2004-2010.
[11] 张晗, 张磊, 刘洋. 龙骨、牡蛎化学成分、药理作用比较研究[J]. 中国中药杂志, 2011, 36(13): 1839-1840.
[12] 郑芳昊, 罗佳波. 桂枝对大鼠中枢神经系统作用的研究[J]. 中药药理与临床, 2014, 30(4): 76-79.
[13] 张丹丹, 叶晓川. 基于肠道菌群和代谢组学探讨茯苓酸性多糖宁心的作用机制[J]. 中华中医药杂志, 2022, 37(5): 2575-2583.
[14] 杜怡雯, 冯江毅, 胡黎文, 等. 大黄的药理活性研究及临床应用[J]. 中医临床研究, 2018, 10(25): 24-27.
[15] 俞婷, 高崎, 朱国琴. 人参皂苷抗心肌缺血中医病机及作用机制的研究进展[J]. 上海医药, 2020, 41(9): 41-46.
[16] 贾彩霞, 陈建新, 高阔, 等. 川芎治疗心力衰竭的网络药理学研究[J]. 世界中医药, 2020, 15(8): 1093-1097.